Search details
1.
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
Cancer Discov
; 13(4): 928-949, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36715552
2.
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 9(12): 1669-1677, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37824137
3.
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.
Clin Cancer Res
; 29(18): 3603-3611, 2023 09 15.
Article
in English
| MEDLINE | ID: mdl-37227187
4.
Twenty-five year results of the national cancer institute randomized breast conservation trial.
Breast Cancer Res Treat
; 132(1): 197-203, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22113254
5.
PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM-Deficient Tumors and Potent Synergy With PARP Inhibitors.
Mol Cancer Ther
; 21(11): 1722-1728, 2022 11 03.
Article
in English
| MEDLINE | ID: mdl-35999657
6.
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.
Nat Commun
; 13(1): 2023, 2022 04 19.
Article
in English
| MEDLINE | ID: mdl-35440132
7.
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies.
Sci Transl Med
; 13(578)2021 01 27.
Article
in English
| MEDLINE | ID: mdl-33504652
8.
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.
Cancer Cell
; 39(4): 566-579.e7, 2021 04 12.
Article
in English
| MEDLINE | ID: mdl-33848478
9.
Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors.
Cancer Chemother Pharmacol
; 86(4): 475-486, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32897402
10.
Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score.
Int J Radiat Oncol Biol Phys
; 70(1): 90-5, 2008 Jan 01.
Article
in English
| MEDLINE | ID: mdl-17855015
11.
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors.
J Clin Oncol
; 36(16): 1594-1602, 2018 06 01.
Article
in English
| MEDLINE | ID: mdl-29252124
12.
Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot study.
Int J Radiat Oncol Biol Phys
; 65(4): 1008-13, 2006 Jul 15.
Article
in English
| MEDLINE | ID: mdl-16730138
13.
Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy.
Int J Radiat Oncol Biol Phys
; 62(5): 1316-21, 2005 Aug 01.
Article
in English
| MEDLINE | ID: mdl-16029787
14.
Early ipsilateral breast tumor recurrences after breast conservation affect survival: an analysis of the National Cancer Institute randomized trial.
Int J Radiat Oncol Biol Phys
; 62(3): 785-9, 2005 Jul 01.
Article
in English
| MEDLINE | ID: mdl-15936560
15.
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.
Int J Radiat Oncol Biol Phys
; 74(4): 1040-6, 2009 Jul 15.
Article
in English
| MEDLINE | ID: mdl-19117692
16.
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
Cancer
; 98(4): 697-702, 2003 Aug 15.
Article
in English
| MEDLINE | ID: mdl-12910512
Results
1 -
16
de 16
1
Next >
>>